Is this you? Create Your Porfile
Avatar

Parker Fabienne

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Parker Fabienne is active.

Explore More

Publication

Featured researches published by Parker Fabienne.

Archive | 2008

MONOKLONALE ANTIKÖRPER GEGEN DAS PROTEIN G3BP UND DEREN VERWENDUNGEN

Parker Fabienne; Kenigsberg Mireille; Duchesne Marc; Barlat Isabelle

Archive | 2006

Peptider, der er i stand til at binde sig til GAP-proteinets SH3-domæne, nukleotidsekvenser, der koder derfor, fremstilling og anvendelse deraf

Schweighoffer Fabien; Parker Fabienne; Tocque Bruno; Duchesne Marc; Faucher Didier

Archive | 2006

PEPTIDE, DIE FÄHIG SIND DIE SH3-DOMÄNE DES GAP-PROTEINS ZU BINDEN, IHRE KODIERENDE DNS, IHRE ZUBEREITUNG UND VERWENDUNG

Duchesne Marc; Faucher Didier; Parker Fabienne; Schweighoffer Fabien; Tocque Bruno

Archive | 2006

PEPTIDOS CAPACES DE UNIRSE AL DOMINIO SH3 DE LA PROTEINA GAP, SECUENCIAS NUCLEOTIDICAS CODIFICADORAS PARA ESTOS PEPTIDOS, SU PREPARACION Y SU UTILIZACION.

Duchesne Marc; Faucher Didier; Parker Fabienne; Schweighoffer Fabien; Tocque Bruno

Archive | 2004

Transgenic animal model of Parkinson's disease, useful in screening for agents effective against neurodegenerative diseases, contains a parkin gene with a deletion in exon 3

Brice Alexis; Perriquet Magali; Bohme Andrees; Duchesne Marc; Itier Jean Michel; Parker Fabienne; Pradier Laurent; Pratt Jeremy; Ret Gwenaelle; Rooney Thomas

Archive | 2003

Polypeptide capable of interacting with the GAP protein SH3 domain, antibody directed against the polypeptide, nucleotide sequence encoding such polypeptide, pharmaceutical composition containing the polypeptide and use of the above antibody, polypeptide and the nucleotide

Duchesne Marc; Faucher Didier; Parker Fabienne; Schweighoffer Fabien; Tocque Bruno

Archive | 1997

PEPTIDES CAPABLE OF BOND TO GAP PROTEIN SH3 REGION, NUCLEOTIDE SEQUENCE ENCODING SUCH PEPTIDES, PROCESS OF THEIR PREPARATION AND USE

Duchesne Marc; Faucher Didier; Parker Fabienne; Schweighoffer Fabien; Tocque Bruno

Archive | 1997

Peptídio capaz de interagir com o domínio sh3 da proteína gap anticorpo ou fragmento de anticorpo dirigido contra um polipeptídeo sequência nucleotídica codificando para um polipeptídio ácido nucléico anti-sentido capaz de inibir ao menos parcialmente a produção de polipeptídeos sua utilização composição farmacêutica e utilização de um anticorpo ou fragmento de anticorpo

Duchesne Marc; Parker Fabienne; Faucher Didier; Schweighoffer Fabien; Tocque Bruno

Archive | 1997

Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, näitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö

Duchesne Marc; Faucher Didier; Parker Fabienne; Schweighoffer Fabien; Tocque Bruno

Archive | 1997

Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav

Duchesne Marc; Faucher Didier; Parker Fabienne; Schweighoffer Fabien; Tocque Bruno

Explore More

Collaboration

Dive into the Parker Fabienne's collaboration.

Top Co-Authors
Avatar

Duchesne Marc

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Tocque Bruno

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Faucher Didier

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Schweighoffer Fabien

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Bohme Andrees

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge